Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Gilead Sciences - 28 Year Stock Price History | GILD

Historical daily share price chart and data for Gilead Sciences since 1992 adjusted for splits. The latest closing stock price for Gilead Sciences as of February 14, 2020 is 67.56.
  • The all-time high Gilead Sciences stock closing price was 122.21 on June 23, 2015.
  • The Gilead Sciences 52-week high stock price is 71.19, which is 5.4% above the current share price.
  • The Gilead Sciences 52-week low stock price is 60.89, which is 9.9% below the current share price.
  • The average Gilead Sciences stock price for the last 52 weeks is 65.34.
  
Gilead Sciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 65.2958 65.2300 68.9900 62.6300 67.5600 3.97%
2019 65.6757 63.4400 70.0500 61.6200 64.9800 3.88%
2018 73.8243 74.1000 88.8000 60.5400 62.5500 -12.69%
2017 72.3252 74.1600 85.4700 64.1200 71.6400 0.04%
2016 83.5809 98.0100 102.2900 71.6100 71.6100 -29.23%
2015 106.5288 94.9100 122.2100 94.8000 101.1900 7.35%
2014 89.5787 75.2100 114.2200 65.4800 94.2600 25.51%
2013 56.0605 37.5300 75.2000 37.4750 75.1000 104.49%
2012 28.2605 20.9300 38.1700 20.9300 36.7250 79.45%
2011 19.9639 18.2900 21.6050 17.6700 20.4650 12.94%
2010 19.6352 21.6500 24.7250 15.9150 18.1200 -16.25%
2009 23.0576 26.0900 26.4000 20.7200 21.6350 -15.39%
2008 24.5922 22.6700 28.5500 18.7350 25.5700 11.15%
2007 19.7900 15.7875 23.8700 15.6825 23.0050 41.72%
2006 15.4776 13.6750 17.4375 13.4375 16.2325 23.51%
2005 10.5689 8.6825 13.9075 7.7600 13.1425 50.24%
2004 8.0435 7.2525 9.7600 6.4700 8.7475 20.08%
2003 6.4362 4.3613 8.7488 4.0375 7.2850 71.41%
2002 4.2569 3.8394 4.9638 3.3188 4.2500 3.47%
2001 3.1340 2.3166 4.5131 1.6894 4.1075 58.47%
2000 2.3545 1.7597 3.6313 1.3575 2.5919 53.22%
1999 1.6682 1.2422 2.8869 1.1172 1.6916 31.84%
1998 0.9967 1.1916 1.3516 0.5703 1.2831 7.35%
1997 0.9798 0.7656 1.4416 0.6759 1.1953 52.99%
1996 0.8862 1.0194 1.2734 0.5391 0.7813 -21.87%
1995 0.5761 0.2930 1.0078 0.2930 1.0000 236.81%
1994 0.3143 0.3750 0.4375 0.2188 0.2969 -20.83%
1993 0.4623 0.5703 0.5978 0.3359 0.3750 -37.67%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $85.473B $22.449B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.810B 15.07
CSL (CSLLY) Australia $100.765B 0.00
Vertex Pharmaceuticals (VRTX) United States $63.215B 57.37
Biogen (BIIB) United States $57.963B 9.90
Regeneron Pharmaceuticals (REGN) United States $43.958B 18.62
Illumina (ILMN) United States $43.941B 45.43
Alexion Pharmaceuticals (ALXN) United States $22.707B 10.56
Seattle Genetics (SGEN) United States $20.339B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.638B 0.00
Incyte (INCY) United States $17.006B 36.49
BioMarin Pharmaceutical (BMRN) United States $15.988B 0.00
Genmab (GNMSF) Denmark $14.741B 65.11
Alnylam Pharmaceuticals (ALNY) United States $14.490B 0.00
Galapagos (GLPG) Belgium $14.198B 36.58
Exact Sciences (EXAS) United States $12.747B 0.00
Bio-Rad Laboratories (BIO.B) United States $12.078B 56.43
BeiGene (BGNE) Cayman Islands $10.449B 0.00
Sarepta Therapeutics (SRPT) United States $9.349B 0.00
QIAGEN (QGEN) Netherlands $8.375B 25.79
Bio-Techne Corp (TECH) United States $7.997B 54.73
Guardant Health (GH) United States $7.916B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.099B 0.00
BioNTech SE (BNTX) Germany $6.958B 0.00
Reata Pharmaceuticals (RETA) United States $6.831B 0.00
Ascendis Pharma (ASND) Denmark $6.732B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.730B 17.11
Moderna (MRNA) United States $6.394B 0.00
Exelixis (EXEL) United States $6.311B 17.75
Amarin (AMRN) Ireland $6.294B 0.00
ARGENX SE-ADR (ARGX) Netherlands $6.105B 0.00
Repligen (RGEN) United States $5.517B 99.97
Acceleron Pharma (XLRN) United States $4.972B 0.00
Bluebird Bio (BLUE) United States $4.942B 0.00
China Biologic Products (CBPO) China $4.597B 25.89
Adaptive Biotechnologies (ADPT) United States $3.913B 0.00
MorphoSys AG (MOR) Germany $3.898B 0.00
Mirati Therapeutics (MRTX) United States $3.635B 0.00
Blueprint Medicines (BPMC) United States $3.619B 0.00
NeoGenomics (NEO) United States $3.569B 189.89
Immunomedics (IMMU) United States $3.550B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.532B 0.00
Zai Lab (ZLAB) China $3.517B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.395B 57.53
Emergent Biosolutions (EBS) United States $3.261B 32.40
MyoKardia (MYOK) United States $3.254B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.157B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.104B 0.00
Halozyme Therapeutics (HALO) United States $3.092B 0.00
Genmab (GMAB) Denmark $3.074B 6.33
Alkermes (ALKS) Ireland $2.804B 222.13
Amicus Therapeutics (FOLD) United States $2.798B 0.00
UniQure (QURE) Netherlands $2.756B 0.00
Insmed (INSM) United States $2.737B 0.00
Arena Pharmaceuticals (ARNA) United States $2.706B 6.29
Denali Therapeutics (DNLI) United States $2.441B 0.00
Epizyme (EPZM) United States $2.209B 0.00
RA PHARMCTL INC (RARX) United States $2.201B 0.00
Fate Therapeutics (FATE) United States $2.183B 0.00
Principia Biopharma (PRNB) United States $2.120B 0.00
Alector (ALEC) United States $2.068B 0.00
REGENXBIO (RGNX) United States $1.980B 0.00
Zymeworks (ZYME) Canada $1.889B 0.00
Ligand Pharmaceuticals (LGND) United States $1.708B 49.86
Arvinas (ARVN) United States $1.698B 0.00
Akcea Therapeutics (AKCA) United States $1.686B 0.00
Zealand Pharma (ZEAL) Denmark $1.595B 0.00
Coherus BioSciences (CHRS) United States $1.525B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.465B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.456B 0.00
Myriad Genetics (MYGN) United States $1.448B 25.55
Editas Medicine (EDIT) United States $1.376B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Intra-Cellular Therapies (ITCI) United States $1.266B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.212B 0.00
Athenex (ATNX) United States $1.206B 0.00
PHARMA MAR SA (PHMMF) Spain $1.184B 0.00
Revance Therapeutics (RVNC) United States $1.143B 0.00
Twist Bioscience (TWST) United States $1.070B 0.00
Adverum Biotechnologies (ADVM) United States $1.020B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.014B 0.00
Mesoblast (MESO) Australia $0.948B 0.00
Pharming Group (PHGUF) Netherlands $0.908B 0.00
Sangamo Therapeutics (SGMO) United States $0.878B 0.00
Cytokineticsorporated (CYTK) United States $0.877B 0.00
DBV Technologies S.A (DBVT) France $0.861B 0.00
Vericel (VCEL) United States $0.852B 317.83
Codexis (CDXS) United States $0.821B 0.00
Heska (HSKA) United States $0.807B 206.14
ANI Pharmaceuticals (ANIP) United States $0.794B 13.54
Cellectis S.A (CLLS) France $0.742B 0.00
Retrophin (RTRX) United States $0.712B 0.00
Cara Therapeutics (CARA) United States $0.712B 0.00
Intrexon (PGEN) United States $0.695B 0.00
GENFIT S.A (GNFT) France $0.694B 0.00
Intellia Therapeutics (NTLA) United States $0.678B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.677B 5.70
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.640B 0.00
NantKwest (NK) United States $0.620B 0.00
Anika Therapeutics (ANIK) United States $0.592B 19.20
UROGEN PHARMA (URGN) United States $0.586B 0.00
Kadmon Holdings (KDMN) United States $0.586B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.576B 0.00
AC Immune SA (ACIU) Switzerland $0.576B 13.31
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.552B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.538B 0.00
Prothena (PRTA) Ireland $0.521B 0.00
Clovis Oncology (CLVS) United States $0.517B 0.00
Arcus Biosciences (RCUS) United States $0.506B 0.00
Agenus (AGEN) United States $0.503B 0.00
Bellus Health (BLU) Canada $0.493B 0.00
Puma Biotechnology (PBYI) United States $0.477B 0.00
BioDelivery Sciences (BDSI) United States $0.472B 0.00
Compugen (CGEN) Israel $0.463B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Sorrento Therapeutics (SRNE) United States $0.456B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.449B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.437B 0.00
Merus (MRUS) Netherlands $0.436B 0.00
Dynavax Technologies (DVAX) United States $0.434B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.421B 0.00
Inovio Pharmaceuticals (INO) United States $0.421B 0.00
Precision BioSciences (DTIL) United States $0.420B 0.00
PDL BioPharma (PDLI) United States $0.419B 10.49
AnaptysBio (ANAB) United States $0.415B 0.00
Cue Biopharma (CUE) United States $0.399B 0.00
Avid Bioservices (CDMO) United States $0.383B 0.00
Mersana Therapeutics (MRSN) United States $0.373B 0.00
Kindred Biosciences (KIN) United States $0.369B 0.00
Stemline Therapeutics (STML) United States $0.345B 0.00
Gritstone Oncology (GRTS) United States $0.339B 0.00
Syros Pharmaceuticals (SYRS) United States $0.334B 0.00
Cellular Biomedicine (CBMG) United States $0.329B 0.00
CytomX Therapeutics (CTMX) United States $0.324B 0.00
Albireo Pharma (ALBO) United States $0.314B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.308B 2.13
AMAG Pharmaceuticals (AMAG) United States $0.302B 0.00
MannKind (MNKD) United States $0.301B 0.00
Starpharma Holdings (SPHRY) Australia $0.290B 0.00
Kamada (KMDA) Israel $0.290B 12.06
WAVE Life Sciences (WVE) Singapore $0.277B 0.00
IVERIC Bio (ISEE) United States $0.273B 0.00
VBI Vaccines (VBIV) United States $0.273B 0.00
Aduro Biotech (ADRO) United States $0.272B 0.00
POXEL SA FRANCE (PXXLF) France $0.271B 0.00
OSMOTICA PHARM (OSMT) United States $0.264B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.264B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.260B 0.00
Geron (GERN) United States $0.258B 0.00
Sutro Biopharma (STRO) United States $0.256B 0.00
Biofrontera AG (BFRA) Germany $0.253B 0.00
Novavax (NVAX) United States $0.247B 0.00
Seres Therapeutics (MCRB) United States $0.246B 0.00
ChromaDex (CDXC) United States $0.244B 0.00
Kala Pharmaceuticals (KALA) United States $0.239B 0.00
XOMA (XOMA) United States $0.238B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.236B 0.00
Protagonist Therapeutics (PTGX) United States $0.227B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.222B 0.00
Prometic Life Sciences (LMNL) Canada $0.221B 0.00
Theratechnologies (THTX) Canada $0.215B 0.00
Alcobra (ARCT) United States $0.210B 0.00
Fortress Biotech (FBIO) United States $0.210B 0.00
ADMA Biologics Inc (ADMA) United States $0.208B 0.00
Arbutus Biopharma (ABUS) Canada $0.208B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.205B 0.00
Exicure (XCUR) United States $0.205B 0.00
Cerecor (CERC) United States $0.201B 0.00
Athersys (ATHX) United States $0.194B 0.00
Affimed (AFMD) Germany $0.193B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.192B 0.00
TELA Bio (TELA) United States $0.180B 0.00
Strongbridge Biopharma (SBBP) United States $0.178B 4.77
Spero Therapeutics (SPRO) United States $0.172B 0.00
Windtree Therapeutics (WINT) United States $0.168B 0.00
Five Prime Therapeutics (FPRX) United States $0.165B 0.00
Abeona Therapeutics (ABEO) United States $0.162B 0.00
VTv Therapeutics (VTVT) United States $0.157B 0.00
Selecta Biosciences (SELB) United States $0.157B 0.00
Dyadic (DYAI) United States $0.154B 0.00
Aptinyx (APTX) United States $0.152B 0.00
Verastem (VSTM) United States $0.149B 0.00
Celyad SA (CYAD) Belgium $0.143B 0.00
Liquidia Technologies (LQDA) United States $0.142B 0.00
PHASEBIO PHARMA (PHAS) United States $0.137B 0.00
ARAVIVE, INC (ARAV) United States $0.136B 0.00
Antibe Therapeutics (ATBPF) Canada $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Menlo Therapeutics (MNLO) United States $0.124B 0.00
Happiness Biotech Group (HAPP) China $0.119B 0.00
Arsanis (XFOR) United States $0.115B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.115B 0.00
Clearside Biomedical (CLSD) United States $0.112B 0.00
OvaScience (MLND) United States $0.107B 0.00
Enzo Biochem (ENZ) United States $0.106B 0.00
Prima BioMed (IMMP) Australia $0.104B 0.00
Northwest Biotherapeutics (NWBO) United States $0.103B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.094B 0.00
Applied Genetic Technologies (AGTC) United States $0.093B 0.00
Vaccinex (VCNX) United States $0.092B 0.00
SESEN BIO, INC (SESN) United States $0.091B 0.00
Emmaus Life Sciences (EMMA) United States $0.090B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.090B 0.00
Proteostasis Therapeutics (PTI) United States $0.087B 0.00
Acorda Therapeutics (ACOR) United States $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
AIT Therapeutics (XAIR) United States $0.085B 0.00
Checkpoint Therapeutics (CKPT) United States $0.084B 0.00
Pluristem Therapeutics (PSTI) Israel $0.083B 0.00
Catalyst Biosciences (CBIO) United States $0.079B 0.00
Orgenesis (ORGS) United States $0.079B 5.08
Synlogic (SYBX) United States $0.078B 0.00
Trevena (TRVN) United States $0.072B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.067B 0.00
Advaxis (ADXS) United States $0.061B 0.00
China Health Industries Holdings (CHHE) China $0.058B 17.78
NewLink Genetics (NLNK) United States $0.058B 0.00
Soligenix (SNGX) United States $0.058B 0.00
DiaMedica Therapeutics (DMAC) United States $0.056B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Curis (CRIS) United States $0.048B 0.00
Idera Pharmaceuticals (IDRA) United States $0.046B 0.00
Organovo Holdings (ONVO) United States $0.043B 0.00
CollPlant Holdings (CLGN) Israel $0.041B 0.00
Evogene (EVGN) Israel $0.039B 0.00
Celldex Therapeutics (CLDX) United States $0.037B 0.00
Entera Bio (ENTX) Israel $0.036B 0.00
AquaBounty Technologies (AQB) United States $0.036B 0.00
Alimera Sciences (ALIM) United States $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.031B 0.00
Celsion (CLSN) United States $0.031B 0.00
Pulmatrix (PULM) United States $0.030B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Stellar Biotechnologies (EDSA) Canada $0.029B 0.00
Oncobiologics (OTLK) United States $0.028B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
VIVUS (VVUS) United States $0.027B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.027B 0.00
Novogen (KZIA) Australia $0.025B 0.00
Unum Therapeutics (UMRX) United States $0.025B 0.00
AEterna Zentaris (AEZS) United States $0.024B 0.00
Cleveland BioLabs (CBLI) United States $0.024B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
Aptevo Therapeutics (APVO) United States $0.022B 0.00
Titan Pharmaceuticals (TTNP) United States $0.017B 0.00
Aytu Bioscience (AYTU) United States $0.016B 0.00
Genetic Technologies (GENE) Australia $0.016B 0.00
Cesca Therapeutics (THMO) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.013B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
TOCAGEN INC (TOCA) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.004B 0.00